BREAKING [Thread]
1. Janssen Pharmaceuticals will grant @aspenpharma a license 2 fill + finish #JnJ's #COVID19 jab under its own brand + sell it to African countries. Currently, the jabs Aspen "fill and finish" have to be handed back to JnJ + they then sell it to who they want.
1. Janssen Pharmaceuticals will grant @aspenpharma a license 2 fill + finish #JnJ's #COVID19 jab under its own brand + sell it to African countries. Currently, the jabs Aspen "fill and finish" have to be handed back to JnJ + they then sell it to who they want.
2. The jabs that Aspen will "fill and finish" under the new agreement will:
1. Be called Aspenovax (#JnJ will give Aspen the IP rights to make its own brand)
2. Will use drug substance (the key ingredient) supplied by JnJ
1. Be called Aspenovax (#JnJ will give Aspen the IP rights to make its own brand)
2. Will use drug substance (the key ingredient) supplied by JnJ
3. Aspen will be able to sell its Aspenovax jabs (the same thing as a #JnJ jab, just a different name) to
public sector markets in Africa through transactions with designated multilateral organisations and with national governments of member states of the African Union.
public sector markets in Africa through transactions with designated multilateral organisations and with national governments of member states of the African Union.
4. Once the agreement is signed, it will be valid until 31 Dec 2026. There will also be a "good faith" undertaking between Aspen and Janssen to include any new versions of the drug substance (e.g. drug substance developed for new variants or a different booster version).
• • •
Missing some Tweet in this thread? You can try to
force a refresh
